Facit | Cancer Breakthroughs Realized
Facit | Cancer Breakthroughs Realized
  • About
    • About FACIT
    • Our Network
    • Leadership
    • Careers
    • Contact
  • Portfolio
  • Funds
    • Funds Overview
      • Prospects
      • Compass Rose
      • Falcons’ Fortunes
  • News
Normal High

Portfolio Category: Compass Rose

FACIT-36 | DNAStack

October 5, 2021 –

Read More from FACIT-36 | DNAStack

FACIT-46 | QurCan Therapeutics

October 5, 2021 –

Read More from FACIT-46 | QurCan Therapeutics

FACIT-47 | CTRL Therapeutics

October 5, 2021 –

Read More from FACIT-47 | CTRL Therapeutics

FACIT-48 | Xpan Inc

October 5, 2021 –

Read More from FACIT-48 | Xpan Inc

FACIT-56 | Radiant Biotherapeutics

October 5, 2021 –

Read More from FACIT-56 | Radiant Biotherapeutics

FACIT-02 | Robarts Research Institute

October 5, 2021 –

Read More from FACIT-02 | Robarts Research Institute

FACIT-18 | Fluorinov Pharma (Trillium Therapeutics)

October 5, 2021 –

Read More from FACIT-18 | Fluorinov Pharma (Trillium Therapeutics)

FACIT-03 | DVS Sciences (Fluidigm)

October 5, 2021 –

Read More from FACIT-03 | DVS Sciences (Fluidigm)

FACIT-19 | Cellax – OICR

October 5, 2021 –

Read More from FACIT-19 | Cellax – OICR

FACIT-04 | Xagenic

October 5, 2021 –

Read More from FACIT-04 | Xagenic

Posts navigation

  • 1
  • 2
  • 3
  • »
  • Privacy Policy
  • Accessibility
  • Terms & Conditions
  • Reporting Improper Activities

FACIT
MaRS Centre
661 University Ave., Suite 510
Toronto, Ontario, Canada M5G 0A3

E: info@facit.ca